PharmaceuticalsMIXED REPORTS
Lilly to Acquire Centessa for Up to $7.8B
Eli Lilly has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion , according to reports from Reuters, STAT News, and CNBC. The acquisition aims to expand Lilly's portfolio beyond metabolic treatments into sleep disorders and neurological conditions. The UK-based Centes
Mar 31, 12:32 PM ET·2 min read
3 articles from 3 publishers